5 Short Squeeze Stocks To Watch: Unicycle Therapeutics, Getty Images And More

Zinger Key Points
  • A company returns to the top five short squeeze candidates after topping the list previously in February.
  • This week's list contains four of the five names from last week.

Potential short squeeze plays gained steam in 2021 and continued through 2022 with new traders looking for the next huge move.

High short interest and high cost to borrow are among the common traits that could lead to a short squeeze.

Here’s a look at the top five short squeeze candidates this week based on the Fintel short squeeze leaderboard.

Unicycle Therapeutics UNCY: Biotechnology company Unicycle ranks first on the leaderboard for a second straight week. Data shows 39.6% of the float short, in line with last week’s report. The cost to borrow on shares of 231.2% declines slightly from last week’s 241.1%. The stock moved up 37 positions previously on the heels of a funding round and several analyst updates and price target increases.

Related Link: What Is A Short Squeeze? 

Getty Images Holdings GETY: Content creator and image marketplace Getty Images moves up eight positions to rank second on the leaderboard and rank inside the top five candidates once again. Since going public via SPAC merger, the stock has frequently appeared on the list, including topping the list for four straight weeks in February.  Data shows 73.1% of the float short and a cost to borrow of 93.6%.

Kala Pharmaceuticals KALA: Kala ranks third for the week, moving down the leaderboard one position from last week. Data shows 12.6% of the float short and a cost to borrow of 456.8%. The float percent remains in line from last week and the cost to borrow rises from last week’s 644.2%.

Bellerophon Therapeutics BLPH: Bellerophon moved up 274 positions to enter the top five short squeeze candidates last week, with shares up over 500% in the last month. The stock moves one position down the leaderboard to rank fourth for the week. Data shows 14.7% of the float short and a cost to borrow of 167%.

Compass Pathways CMPS: Mental health company Compass Pathways ranks fifth for the week, moving one position down the leaderboard. Data shows 33.8% of the float short and a cost to borrow of 39.1%.

Read Next: Exclusive: GameStop Expert Says Apes Learned So Much About Market, Are Helping Push For SEC Changes 

Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapTrading IdeasFintelFintel short squeezeShort Squeezeshort squeeze candidatesShort squeeze ideas
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!